Novo Nordisk Reassures Investors With Growth Forecast - WSJ
Investors - NBE Therapeutics
Novo Nordisk – Great company but also a great investment ? | value and opportunity
Investors Cozy Up to Danish Stocks - The New York Times
Investors await Novo Nordisk's diabetes pill
Revisiting Novo Nordisk (NYSE:NVO) | Seeking Alpha
Financial results and events
Novo Nordisk invests in production facilities
Novo Nordisk owners launch impact investment fund
Novo Nordisk: Buy The Diabetes Treatment Leader On Recent Weakness (NYSE:NVO) | Seeking Alpha
Novo Nordisk (NVO) Investor Presentation - Slideshow (NYSE:NVO) | Seeking Alpha
Financial results and events
Novo Nordisk plans new investments in Denmark - The Local
Investors angry about insulin woes sue Novo Nordisk in Denmark for $1.75B | FiercePharma
Novo Nordisk A focused healthcare company
Novo Nordisk plans investment in France
Novo Nordisk HQ sells for 305M to Korean investment firm top single-asset sale of 2016 - NJBIZ
Prepared by Imprima de Bussy
Novo Holdings expands investment scope to Asia
Novo Nordisk announces another $22M investment in Clayton - Triangle Business Journal
Contact investor relations
Novo Nordisk - Crunchbase Company Profile & Funding
Investor presentation Citi's Swiss Healthcare Investor ... - Novo Nordisk
What Should Investors Know About Novo Nordisk A/S's (CPH:NOVO B) Growth?
Novo Nordisk investing $117.4M in manufacturing site in Denmark | FiercePharma
Hold NVO Stock for Consistent International Growth | InvestorPlace
Novo Nordisk 0 A focused healthcare company Investor presentation – Merrill Lynch Global Pharmaceutical Conference London, 24 September ppt download
